Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 10, 2008
Company will also present results from the ARRIVE diabetic subset analysis, the ATLAS Workhorse and Direct Stenting trials and ATLAS data on small vessels and long lesions
-
Oct 9, 2008
The recent turmoil in the financial markets and bankruptcy of Lehman Brothers triggered automatic share selling
-
Oct 8, 2008
Company to discuss these and other issues on its third quarter earnings call on October 23 at 8:00 a.m.
-
Oct 8, 2008
PERSEUS clinical program to evaluate TAXUS® Element™ Platinum Chromium Stent
-
Oct 1, 2008
Judgment against Company entered in a patent case filed in 1997; Company to appeal
-
Sep 25, 2008
Company also announces FDA approval of TAXUS® Express2™ Stent System for treatment of in-stent restenosis
-
Sep 19, 2008
A live webcast and replay of the September 25 session will be available
-
Sep 15, 2008
Boston Scientific Corporation (NYSE: BSX) announced today a decision by the United States District Court in Delaware. The case involves a patent...
-
Sep 9, 2008
A live webcast and replay of the Tuesday, September 16 session will be available
-
Sep 2, 2008
Company announced positive one-year results from the world's largest post-approval, prospective registry for a single drug-eluting stent (DES)
-
Sep 1, 2008
Overall results demonstrated no statistically significant differences between PCI and CABG in rates of death or myocardial infarction (MI)
-
Aug 29, 2008
Boston Scientific obligation reduced from $250 to $19 million; Company to appeal remaining award
-
Aug 26, 2008
Company to present data from landmark SYNTAX clinical trial
-
Jul 21, 2008
"We were pleased with the quarter, especially with our expense management and working capital initiatives,” said CEO Jim Tobin.
-
Jul 2, 2008
Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms
-
Jun 26, 2008
A live webcast and replay of the July 22 conference call will be available
-
Jun 23, 2008
Legislation would help service veterans and the active armed forces better manage the challenges of chronic pain
-
Jun 19, 2008
Transactions further Company's plans to focus on core businesses and increase shareholder value
-
Jun 9, 2008
Fitch also reaffirmed the Company's long-term credit rating of BB+
-
Jun 5, 2008
A live webcast and replay of the June 11 session will be available
-
Jun 3, 2008
Company announces management changes and further organizational consolidation
-
May 29, 2008
Environmentally focused improvements are hallmark of renovations to Endosurgery headquarters
-
May 28, 2008
Transaction follows the definitive agreement announced on April 16
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
May 20, 2008Positive results presented at Digestive Disease Week® 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an international, multi-center patient registry documenting...